Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® received MHRA approval for both subcutaneous and intravenous formulations, to ...
Regulatory ApprovalFormycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 15.01.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...
Wild edible Swiss chard leaves (Beta vulgaris L. var. cicla): Nutritional ... 2018.25200.6238 Ambhore J, Adhao V, Rafique S, et al. A concise review: Edible mushroom and their medicinal significance.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
At close: January 17 at 4:00:02 PM EST ...
After hours: January 16 at 4:22:23 PM EST Loading Chart for ARTV ...
After hours: 7:54:56 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback